Type I interferon activates MHC class I-dressed CD11b+ conventional dendritic cells to promote protective anti-tumor CD8+ T cell immunity

被引：216

作者：

Duong, Ellen ^{[1
,2
]}

Fessenden, Tim B. ^{[1
]}

Lutz, Emi ^{[1
,3
]}

Dinter, Teresa ^{[1
,2
]}

Yim, Leon ^{[1
]}

Blatt, Sarah ^{[1
]}

Bhutkar, Arjun ^{[1
]}

Wittrup, Karl Dane ^{[1
,3
]}

Spranger, Stefani ^{[1
,2
,4
]}

机构：

[1] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA

[2] MIT, Dept Biol, Cambridge, MA 02139 USA

[3] MIT, Dept Biol Engn, Cambridge, MA USA

[4] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA

来源：

IMMUNITY | 2022年 / 55卷 / 02期

关键词：

ANTIGEN-PRESENTING CELLS; TRANSCRIPTION FACTORS; CROSS-PRESENTATION; TUMOR-CELLS; EXPRESSION; RECEPTOR; INNATE; DIFFERENTIATION; RESPONSES; MELANOMA;

D O I：

10.1016/j.immuni.2021.10.020

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Tumor-infiltrating dendritic cells (DCs) assume varied functional states that impact anti-tumor immunity. To delineate the DC states associated with productive anti-tumor T cell immunity, we compared spontaneously regressing and progressing tumors. Tumor-reactive CD8+ T cell responses in Batf3(-/-) mice lacking type 1 DCs (DC1s) were lost in progressor tumors but preserved in regressor tumors. Transcriptional profiling of intra-tumoral DCs within regressor tumors revealed an activation state of CD11b(+) conventional DCs (DC2s) characterized by expression of interferon (IFN)-stimulated genes (ISGs) (ISG(+) DCs). ISG(+) DC-activated CD8(+) T cells ex vivo comparably to DC1. Unlike cross-presenting DC1, ISG(+) DCs acquired and presented intact tumor-derived peptide-major histocompatibility complex class I (MHC class I) complexes. Constitutive type I IFN production by regressor tumors drove the ISG+ DC state, and activation of MHC class I-dressed ISG(+) DCs by exogenous IFN-b rescued anti-tumor immunity against progressor tumors in Batf3(-/-) mice. The ISG(+) DC gene signature is detectable in human tumors. Engaging this functional DC state may present an approach for the treatment of human disease.

引用

页码：308 / +

页数：26

共 97 条

[1] Loss of function JAK1 mutations occur at high frequency in cancers with microsatellite instability and are suggestive of immune evasion [J].

Albacker, Lee A. ;

Wu, Jeremy ;

Smith, Peter ;

Warmuth, Markus ;

Stephens, Philip J. ;

Zhu, Ping ;

Yu, Lihua ;

Chmielecki, Juliann .

PLOS ONE, 2017, 12 (11)

[2] A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments [J].

Barry, Kevin C. ;

Hsu, Joy ;

Broz, Miranda L. ;

Cueto, Francisco J. ;

Binnewies, Mikhail ;

Combes, Alexis J. ;

Nelson, Amanda E. ;

Loo, Kimberly ;

Kumar, Raj ;

Rosenblum, Michael D. ;

Alvarado, Michael D. ;

Wolf, Denise M. ;

Bogunovic, Dusan ;

Bhardwaj, Nina ;

Daud, Adil, I ;

Ha, Patrick K. ;

Ryan, William R. ;

Pollack, Joshua L. ;

Samad, Bushra ;

Asthana, Saurabh ;

Chan, Vincent ;

Krummel, Matthew F. .

NATURE MEDICINE, 2018, 24 (08) :1178-1191

[3] Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape [J].

Bidwell, Bradley N. ;

Slaney, Clare Y. ;

Withana, Nimali P. ;

Forster, Sam ;

Cao, Yuan ;

Loi, Sherene ;

Andrews, Daniel ;

Mikeska, Thomas ;

Mangan, Niamh E. ;

Samarajiwa, Shamith A. ;

de Weerd, Nicole A. ;

Gould, Jodee ;

Argani, Pedram ;

Moeller, Andreas ;

Smyth, Mark J. ;

Anderson, Robin L. ;

Hertzog, Paul J. ;

Parker, Belinda S. .

NATURE MEDICINE, 2012, 18 (08) :1224-1231

[4] NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control [J].

Boettcher, Jan P. ;

Bonavita, Eduardo ;

Chakravarty, Probir ;

Blees, Hanna ;

Cabeza-Cabrerizo, Mar ;

Sammicheli, Stefano ;

Rogers, Neil C. ;

Sahai, Erik ;

Zelenay, Santiago ;

Reis e Sousa, Caetano .

CELL, 2018, 172 (05) :1022-+

[5] Inflammatory Type 2 cDCs Acquire Features of cDC1s and Macrophages to Orchestrate Immunity to Respiratory Virus Infection [J].

Bosteels, Cedric ;

Neyt, Katrijn ;

Vanheerswynghels, Manon ;

van Helden, Mary J. ;

Sichien, Dorine ;

Debeuf, Nincy ;

De Prijck, Sofie ;

Bosteels, Victor ;

Vandamme, Niels ;

Martens, Liesbet ;

Saeys, Yvan ;

Louagie, Els ;

Lesage, Manon ;

Williams, David L. ;

Tang, Shiau-Choot ;

Mayer, Johannes U. ;

Ronchese, Franca ;

Scott, Charlotte L. ;

Hammad, Hamida ;

Guilliams, Martin ;

Lambrecht, Bart N. .

IMMUNITY, 2020, 52 (06) :1039-+

[6] Distinct Transcriptional Programs Control Cross-Priming in Classical and Monocyte-Derived Dendritic Cells [J].

Briseno, Carlos G. ;

Haldar, Malay ;

Kretzer, Nicole M. ;

Wu, Xiaodi ;

Theisen, Derek J. ;

Wumesh, K. C. ;

Durai, Vivek ;

Grajales-Reyes, Gary E. ;

Iwata, Arifumi ;

Bagadia, Prachi ;

Murphy, Theresa L. ;

Murphy, Kenneth M. .

CELL REPORTS, 2016, 15 (11) :2462-2474

[7] Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity [J].

Broz, Miranda L. ;

Binnewies, Mikhail ;

Boldajipour, Bijan ;

Nelson, Amanda E. ;

Pollack, Joshua L. ;

Erle, David J. ;

Barczak, Andrea ;

Rosenblum, Michael D. ;

Daud, Adil ;

Barber, Diane L. ;

Amigorena, Sebastian ;

van't Veer, Laura J. ;

Sperling, Anne I. ;

Wolf, Denise M. ;

Krummel, Matthew F. .

CANCER CELL, 2014, 26 (05) :638-652

[8] Antigen density presented by dendritic cells in vivo differentially affects the number and avidity of primary, memory, and recall CD8+ T cells [J].

Bullock, TNJ ;

Mullins, DW ;

Engelhard, VH .

JOURNAL OF IMMUNOLOGY, 2003, 170 (04) :1822-1829

[9] The Efficacy of Radiotherapy Relies upon Induction of Type I Interferon-Dependent Innate and Adaptive Immunity [J].

Burnette, Byron C. ;

Liang, Hua ;

Lee, Youjin ;

Chlewicki, Lukasz ;

Khodarev, Nikolai N. ;

Weichselbaum, Ralph R. ;

Fu, Yang-Xin ;

Auh, Sogyong L. .

CANCER RESEARCH, 2011, 71 (07) :2488-2496

[10] Integrating single-cell transcriptomic data across different conditions, technologies, and species [J].

Butler, Andrew ;

Hoffman, Paul ;

Smibert, Peter ;

Papalexi, Efthymia ;

Satija, Rahul .

NATURE BIOTECHNOLOGY, 2018, 36 (05) :411-+

← 1 2 3 4 5 6 7 8 9 10 →